Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma - Wikidata - wikimedia - TriplyDB

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

http://www.wikidata.org/entity/Q24645168

about

Increased antiprotease activity of the SERPINB3 polymorphic variant SCCA-PD Study of the early steps of the Hepatitis B Virus life cycle Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease Present and future possibilities for early diagnosis of hepatocellular carcinoma SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells.Correlation analysis of liver tumor-associated genes with liver regeneration Comparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinoma.SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3).Hepatic progenitor cells express SerpinB3 Tissue expression of squamous cellular carcinoma antigen and Ki67 in hepatocellular carcinoma-correlation with prognosis: a historical prospective study Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysis Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.SERPINB3 is associated with longer survival in transgenic mice.SERPINB3 and B4: From biochemistry to biology An emerging role for the nuclear localization of maspin in the suppression of tumor progression and metastasis.Serpins, immunity and autoimmunity: old molecules, new functions.Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.Serum protein biomarkers relevant to hepatocellular carcinoma and their detection.Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.SERPINB3 modulates TGF-beta expression in chronic liver disease.Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells.SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I.HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.Inhibition of Staphylococcus aureus cysteine proteases by human serpin potentially limits staphylococcal virulence.Cholesteatoma growth and proliferation: relevance with serpin B3.Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice.SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection.Expression of squamous cell carcinoma antigen-1 in liver enhances the uptake of hepatitis B virus envelope-derived bio-nanocapsules in transgenic rats.Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure.Network-based association analysis to infer new disease-gene relationships using large-scale protein interactions.Effect of Productive Human Papillomavirus 16 Infection on Global Gene Expression in Cervical Epithelium

P2860

Q24295178-285DFF5F-B782-4523-A5B4-C21ED1D2C5A7 Q24791089-05E125C2-08A7-4930-AD3D-2CC74FED823F Q26774517-5941D78C-8294-4A75-86F6-6D4991B7E524 Q28080175-D90DA38D-AA26-44CF-ABB0-CC9878972506 Q28727095-2CB54E1D-40FC-41E0-B7B5-229A01A0550A Q33612167-A15317F4-4127-4CF6-95EE-277D62555642 Q33683019-902A7DDC-2FD2-4335-A7FC-1B3B29DDC67B Q33794042-A3D1CDD1-87B7-4947-B6ED-FE342FCB3F8F Q34233029-0476A82C-E592-4DD4-B80D-CD2A6523DB21 Q34362542-398C30BE-74DA-4D15-89A3-0F0D0DF36151 Q34476786-D5BD3D0F-6FA2-4010-9EC7-B4FE1670C6E1 Q35092061-558B6A17-52AE-4BA4-8F42-949BBA06E3CB Q35777269-EEFCF0D6-6A5C-473E-AED0-E6B8DC2487C1 Q35948769-9A0F028B-B6B3-4C39-8554-CE548D950456 Q36172428-316475CF-2512-4281-B6D5-F46EB4FEF95E Q36346439-96CC29B7-E0A9-466D-8DA2-CB7FA10F2FF4 Q37218919-9F892560-874C-464E-B6CC-74E590D76B32 Q37256580-02C38D29-FE8A-4BDA-AE19-14358B8B888F Q37653336-402984C0-80B6-4093-9942-7D0A428A9E46 Q37952002-057E3189-0E97-4290-A033-45DCE900522D Q38074594-540C4A7E-7FB8-403E-BE64-D2E3D78FAC03 Q38450711-C1C5DE6F-88D8-432E-A768-A260B2A86C1F Q38647536-7C5BBE0D-9355-4E68-8014-5D74220F9C85 Q38924905-F6E4F547-D318-4AA4-9826-5E623830F1C5 Q38985923-DEAB2FBB-65BD-4523-A4FD-11EFB910784E Q39730718-15AF0459-4544-4940-9263-2F1AF4D43DBA Q39907001-598D1CC4-4D23-4D53-AABD-23131E6F56C6 Q40720441-8A5C0ECE-56C8-406E-AF5B-72942DCFF5E7 Q41528078-65E62F2B-4928-4CAA-A611-78451B1F090B Q42510932-2397CB1D-DB91-418A-96EC-66F58B5C3CAB Q42699349-FB0DCEFE-429E-4298-892E-FA28FD2CB258 Q44061770-8468E288-BB9C-4C9C-8D69-9827DDB135B6 Q44070994-B6604E0E-5A62-49E2-9AE1-8A2EA0960F8C Q45355954-886221C8-6280-4B07-9938-DA0EC45C2B8D Q45389071-FFDE4D32-168E-493E-BD09-E75D34DB4456 Q48192189-A2D0DDFB-394E-40D7-973D-4D7D5D26B468 Q55492382-F0E88BFD-31D6-41A4-A6C9-BFD6062C816D Q57469947-C2647B59-076F-4837-BB4E-2BF4FD9C40F2

P2860

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

http://www.wikidata.org/entity/Q24645168

description

2004 nî lūn-bûn

@nan

2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

@ast

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

@en

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

@nl

type

label

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

@ast

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

@en

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

@nl

prefLabel

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

@ast

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

@en

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

@nl

P1433

Q24645168-7A06478C-B800-42F0-BA49-A512D71CBBA4

P1476

Q24645168-7F0B9C53-8B2C-463B-A361-B6B762583372

P2093

Q24645168-2C7884F4-7F9D-47C4-84E6-86B469E01376

Q24645168-3694D278-603B-4A71-A98A-78BEDE0F2F1F

Q24645168-3FD58FDF-B857-4EC1-B1B9-5C5A91298E9E

Q24645168-73955AF0-30D8-401E-9306-349FFF25DBFB

Q24645168-88FD6A42-2F2A-4BCB-AF23-03E1649673DD

Q24645168-8A4CA990-21FD-4C92-B6B0-B4CBEAB3CB4A

Q24645168-9A36ED4F-9817-4496-9F2A-BC810CE6BD66

Q24645168-A9630F29-5DB3-469D-A68A-59E1CE08697D

Q24645168-B1164DB6-AC25-4CDF-8D04-D035226BBDA9

Q24645168-FBA51045-3C50-4DB6-8FA7-E9758604D7A7

P2860

Q24645168-05694423-234D-4DD0-83DD-462040453A98

Q24645168-0AA7D41E-6DE4-4B3F-86C6-416C05CE8147

Q24645168-0D5C06D7-DAB2-45D4-BD54-8E1B2CB442CD

Q24645168-22FD528B-5F5E-4D28-845F-F81A6A9449B3

Q24645168-36790341-4AC9-4989-9D83-57D570589F37

Q24645168-7F4FB0CF-8A83-4E2F-877A-FD5C1DB7108F

Q24645168-98265388-FC83-4AE6-ABE2-B510990EA85D

Q24645168-99CF537D-1A49-497D-8046-0FC5DC72819E

Q24645168-A025DFF1-C018-4EB4-949E-B651F6692ACC

Q24645168-A0D01E16-4E5F-442E-BBD0-5A96344678B1

P2888

Q24645168-782620E3-D84E-4AB5-BCF8-95088B87E46E

P304

Q24645168-D2F5C329-7EE5-4947-AE99-19A709ABB29C

P31

Q24645168-837E3CA3-F53C-4B6D-9CA2-1D2706F4DE79

P3181

Q24645168-0F3D902E-C002-44A8-B964-1654E62F92D3

P356

Q24645168-64183BA1-8FA5-43B4-ABC4-2166D5E66CB4

P407

Q24645168-74F5CCB4-D1E4-4673-998E-E1B17CE8C64F

P433

Q24645168-BF609750-29A6-45A8-B40B-32FA07DD6E23

P478

Q24645168-5C14AF2C-5AA7-4570-ABF3-0E51B6E36ABD

P50

Q24645168-D782B825-9A80-451C-AECE-E48EF252D1DD

P577

Q24645168-BF429CB7-A6A3-4642-8108-196AB951D4BB

P5875

Q24645168-8FBBEBC9-010E-4B62-A010-CABDDB78FB29

P6179

Q24645168-36B0C061-0969-4553-B346-B8F4DC393316

P698

Q24645168-3E229F55-889B-423D-B761-D816E677CB70

P921

Q24645168-ACB5891E-19DD-4A26-9403-B1BB9DC19D30

P932

Q24645168-0E340526-B085-42FE-BAD5-2A2F2B9CDE8E

P3181

P356

P1433

British Journal of Cancer

P1476

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

@en

P2093

A Gatta

http://www.w3.org/2001/XMLSchema#string

D Nitti

http://www.w3.org/2001/XMLSchema#string

F Calabrese

http://www.w3.org/2001/XMLSchema#string

G Fassina

http://www.w3.org/2001/XMLSchema#string

L Benvegnù

http://www.w3.org/2001/XMLSchema#string

M G Ruvoletto

http://www.w3.org/2001/XMLSchema#string

M Lise

http://www.w3.org/2001/XMLSchema#string

M Marino

http://www.w3.org/2001/XMLSchema#string

M Valente

http://www.w3.org/2001/XMLSchema#string

P Pontisso

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of a serpin-protease complex shows inhibition by deformation

A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene

Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Structural analysis of human SCC antigen 2 promoter

Molecular cloning of human squamous cell carcinoma antigen 1 gene and characterization of its promoter

Squamous cell carcinoma antigen is a new member of the serine protease inhibitors

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Alpha1-antitrypsin deficiency--a model for conformational diseases.

The evaluation of fine-needle procedures for the diagnosis of focal liver lesions in cirrhosis.

P2888

P304

833-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3214915

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.BJC.6601543

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

Claudio Belluco

P577

2004-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8689529

http://www.w3.org/2001/XMLSchema#string

P6179

1047817117

http://www.w3.org/2001/XMLSchema#string

P698

14970861

http://www.w3.org/2001/XMLSchema#string

P921

P932

2410161

http://www.w3.org/2001/XMLSchema#string